Drug Index

NYSTATIN

Generic: NYSTATIN

Marketing status: Discontinued

Route: ORAL
Class: Cardiovascular
Safety profile: generic
Latest regulatory update: 28 Jun 2002, 12:00 am (UTC)

Structured Monograph

Approval overview NYSTATIN is listed in Drugs@FDA under application 062838 (ANDA). Marketing status: Discontinued Active ingredient NYSTATIN Form and strength TABLET;ORAL - 500,000 UNITS Sponsor SUN PHARM INDUSTRIES Submission history Latest submission status date: 2002-06-28 00:00:00. Submission type: SUPPL.